X
Pharma Advancement
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    FDA Accepts BLA for Recommended

    FDA Accepts BLA for Recommended Biosimilar to Simponi

    Merck to Acquire Verona

    Merck to Acquire Verona Pharma in $10B Deal Boosts COPD Drug

    Emerging Oral Small Molecule Drugs

    Emerging Oral Small-Molecule Drugs for Ultra-Rare Diseases

    FDA Approves Oral Therapy for Treating Hereditary Angioedema

    FDA Approves Oral Therapy for Treating Hereditary Angioedema

    Avadel Pharmaceuticals Receives

    Avadel Pharmaceuticals Receives Orphan Drug Designation from FDA for LUMRYZ™ (sodium oxybate) for Extended-Release Oral Suspension for the Treatment of Idiopathic Hypersomnia

    Robots and AI in Drug

    Robots and AI in Drug Discovery Are Transforming Medicine

    Stringent Policy around COVID Vaccines Laid by FDA

    Stringent Policy around COVID Vaccines Laid by FDA

    Pharmaceutical-Chemicals Market Booms with Rising API Demand

    Pharmaceutical Chemicals Market Booms with Rising API Demand

    Next in Pharma 2025 Innovations

    Next in Pharma 2025: Innovations Shaping the Future

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    FDA Accepts BLA for Recommended

    FDA Accepts BLA for Recommended Biosimilar to Simponi

    Merck to Acquire Verona

    Merck to Acquire Verona Pharma in $10B Deal Boosts COPD Drug

    Emerging Oral Small Molecule Drugs

    Emerging Oral Small-Molecule Drugs for Ultra-Rare Diseases

    FDA Approves Oral Therapy for Treating Hereditary Angioedema

    FDA Approves Oral Therapy for Treating Hereditary Angioedema

    Avadel Pharmaceuticals Receives

    Avadel Pharmaceuticals Receives Orphan Drug Designation from FDA for LUMRYZ™ (sodium oxybate) for Extended-Release Oral Suspension for the Treatment of Idiopathic Hypersomnia

    Robots and AI in Drug

    Robots and AI in Drug Discovery Are Transforming Medicine

    Stringent Policy around COVID Vaccines Laid by FDA

    Stringent Policy around COVID Vaccines Laid by FDA

    Pharmaceutical-Chemicals Market Booms with Rising API Demand

    Pharmaceutical Chemicals Market Booms with Rising API Demand

    Next in Pharma 2025 Innovations

    Next in Pharma 2025: Innovations Shaping the Future

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home News

Peli BioThermal Share Sustainability Solutions at CTS Europe

Content Team by Content Team
17th March 2020
in News, Packaging & Logistic
Peli BioThermal Announces Acquisition of NanoCool

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Peli BioThermal, the global name in temperature-controlled packaging, will highlight how selecting the right packaging helps companies achieve sustainability objectives. They will share expertise and knowledge on sustainability as guest speakers at Clinical Trial Supply Europe, being held in Madrid on March 11 – 12, 2020.

Peli BioThermal will also be hosting roundtable discussions on thermal packaging’s contribution to sustainability in the clinical trial sector alongside exhibiting the company’s high performance shippers for clinical trial applications including; CoolPall™ Flex, Cr?do™ Cube, CoolGuard™ PCM and CoolGuard™ Advance.

Paul Terry, Peli BioThermal’s Director of Sales EMEA, is a key speaker at the annual event which sees delegates from Europe’s largest pharmaceutical companies and biotech innovators congregate to discuss the latest trends in clinical supply chain innovation.

He will host a presentation entitled: Sustainability – contributing to your objectives with your temperature controlled packaging,which will shine a spotlight on issues including:

The use of reusable packaging with regards to sustainability
The impact of temperature controlled packaging in the waste and recycling streams
How choosing the right temperature controlled packaging can support your sustainability programme

Paul Terry said: “Sustainability is increasingly an area of focus across the industry and worldwide. Our reusable shippers and flexible rental program options help clinical trial and life sciences companies to address sustainability issues.

“The clinical trial sector is an area of significant growth for Peli BioThermal and we welcome the opportunity to exhibit our award-winning thermal packaging solutions and services at the conference. With more than 100 network stations and drop points globally, our resuable shipper solutions continue to lead the way when it comes to driving for greater sustainability throughout supply chains worldwide.”

Exhibiting at Stand 12 at CTS Europe, Peli BioThermal will showcase its services and temperature controlled shippers for clinical trials applications demonstrating how these can help achieve sustainability objectives within the growing biopharma industry.

Previous Post

Peli BioThermal Announces Acquisition of NanoCool

Next Post

Cool Chain Association teams up with Cargo iQ for new initiative

Related Posts

FDA Accepts BLA for Recommended
FDA Approvals

FDA Accepts BLA for Recommended Biosimilar to Simponi

22nd July 2025
Merck to Acquire Verona
Drug Development

Merck to Acquire Verona Pharma in $10B Deal Boosts COPD Drug

21st July 2025
ChiRhoClin LogiCare3PL Partners for Drug Distribution
News

ChiRhoClin, LogiCare3PL Partners for Drug Distribution

21st July 2025
Thermo Fisher and Sanofi Partners
Manufacturing

Thermo Fisher and Sanofi Partners for US Drug Manufacturing

21st July 2025
EMA Recommendations to Secure Anti D Immunoglobulins Supply
News

EMA Recommendations to Secure Anti-D Immunoglobulins Supply

15th July 2025
FDA Approves Oral Therapy for Treating Hereditary Angioedema
FDA Approvals

FDA Approves Oral Therapy for Treating Hereditary Angioedema

15th July 2025
Next Post
Cool Chain Association teams up with Cargo iQ for new initiative

Cool Chain Association teams up with Cargo iQ for new initiative

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Subscribe Us

System

  • Search
  • Sitemap
  • RSS Feed

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack
  • Newsletters Archive

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Articles
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In